# Lumizyme

NDC: 58468-0160
Generic name: ALGLUCOSIDASE ALFA
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20100524

FDA application: BLA125291

## Active ingredients

- ALGLUCOSIDASE ALFA: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0160"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0160
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6bfbc45-2d34-439e-8aad-59ee2d53d4df